Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Beger

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Expert Review of Molecular Diagnostics|March 3, 2007
Cambridge Healthtech Institute's 7th Annual, identifying and validating metabolic markers for drug development and clinical studiesRichard D Beger
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standardsRichard D Beger
Drug Discovery Today|April 26, 2006
Computational modeling of biologically active molecules using NMR spectraRichard D Beger
Metabolites|June 25, 2014
A review of applications of metabolomics in cancerRichard D Beger
Journal of Molecular Recognition : JMR|August 31, 2002
Comparative structural connectivity spectra analysis (CoSCoSA) models of steroids binding to the aromatase enzymeRichard D Beger, Jon G Wilkes
Journal of Chemical Information and Modeling|April 6, 2005
Whole-molecule calculation of log p based on molar volume, hydrogen bonds, and simulated 13C NMR spectraLaura K Schnackenberg, Richard D Beger
Pharmacogenomics|October 24, 2006
Monitoring the health to disease continuum with global metabolic profiling and systems biologyLaura K Schnackenberg, Richard D Beger
Environmental Toxicology and Chemistry|August 11, 2016
Rigorous 3-dimensional spectral data activity relationship approach modeling strategy for ToxCast estrogen receptor data classification, validation, and feature extractionSvetoslav H Slavov, Richard D Beger
Toxicology Mechanisms and Methods|December 22, 2009
The role of metabolic biomarkers in drug toxicity studiesLaura K Schnackenberg, Richard D Beger
Drug Discovery Today. Technologies|July 2, 2014
Metabolomic biomarkers: their role in the critical pathLaura K Schnackenberg, Richard D Beger
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Expert Review of Molecular Diagnostics|March 3, 2007
Cambridge Healthtech Institute's 7th Annual, identifying and validating metabolic markers for drug development and clinical studiesRichard D Beger
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standardsRichard D Beger
Drug Discovery Today|April 26, 2006
Computational modeling of biologically active molecules using NMR spectraRichard D Beger
Metabolites|June 25, 2014
A review of applications of metabolomics in cancerRichard D Beger
Journal of Molecular Recognition : JMR|August 31, 2002
Comparative structural connectivity spectra analysis (CoSCoSA) models of steroids binding to the aromatase enzymeRichard D Beger, Jon G Wilkes
Journal of Chemical Information and Modeling|April 6, 2005
Whole-molecule calculation of log p based on molar volume, hydrogen bonds, and simulated 13C NMR spectraLaura K Schnackenberg, Richard D Beger
Pharmacogenomics|October 24, 2006
Monitoring the health to disease continuum with global metabolic profiling and systems biologyLaura K Schnackenberg, Richard D Beger
Environmental Toxicology and Chemistry|August 11, 2016
Rigorous 3-dimensional spectral data activity relationship approach modeling strategy for ToxCast estrogen receptor data classification, validation, and feature extractionSvetoslav H Slavov, Richard D Beger
Toxicology Mechanisms and Methods|December 22, 2009
The role of metabolic biomarkers in drug toxicity studiesLaura K Schnackenberg, Richard D Beger
Drug Discovery Today. Technologies|July 2, 2014
Metabolomic biomarkers: their role in the critical pathLaura K Schnackenberg, Richard D Beger
Pageof 12